Previous Play Slide ShowStop Slide Show Next
Carpentier-Edwards PERIMOUNT
Magna Mitral Heart Valve

The Carpentier-Edwards PERIMOUNT Magna mitral heart valve embodies over 40 years of Edwards innovation in mitral replacement and mitral repair. The PERIMOUNT Magna mitral valve is the ultimate in mitral bioprostheses and is designed to produce a real MAGNAtude of MITRAL performance.

Unmatched implantability
  • Lowest ventricular projection for any stented mitral valve.2,3
  • Wide, expansive sewing cuff with a 15% to 38% increase in effective suture area.
  • Anatomic reference markers to optimize orientation for position and ventricular flow.
Unparalleled durability
  • Built upon the 16-year proven durability of the Carpentier-Edwards PERIMOUNT mitral valve.1
  • The Carpentier-Edwards ThermaFix process* is the only dual-action tissue treatment designed to confront the major causes of calcific SVD.
Unique mitral design
  • The only asymmetric mitral valve designed to enhance coaptive interface between anterior and posterior aspects of the native mitral annulus.
  • Lowest effective profile of any mitral tissue valve with reduced ventricular projection by 40%.2,3

† Compared to PERIMOUNT mitral valve based on labeled valve size.
* No clinical data are available which evaluate the long-term impact of the Edwards Lifesciences tissue treatment in patients.

1. Marchand MA, et al. Fifteen-year experience with the Mitral Carpentier-Edwards PERIMOUNT Pericardial Bioprosthesis. Ann Thorac Surg 2001;71:S236-9. Carpentier-Edwards PERIMOUNT Mitral Pericardial Bioprosthesis 16-year Results. Data on file at Edwards Lifesciences, 2003.
2. “Ventricular protrusion” Mosaic bioprostheses brochure UC200103933 EN, Medtronic, Inc. 2001.
3. “Ventricular protrusion” SJM Biocor Valve brochure. ITEM1809/0705/7.5M/EN/YC. St. Jude
Medical, Inc. 2005.
For professional use. See instructions for use for full prescribing information, including indications, contraindications, warnings, precautions and adverse event.

Edwards Lifesciences devices placed on the European market meeting the essential requirements referred to in Article 3 of the Medical Device Directive 93/42/EEC bear the CE marking of conformity.